Skip to main content

Accelerating Drug Development Through Science and Strategy

Expert DMPK modeling, regulatory affairs, and market access solutions to optimize your path from discovery to patients

Our Services

At Kalvion Sciences, we partner with life sciences organizations to unlock value across the product lifecycle.

DMPK & Clinical Pharmacology

Advanced modeling and simulation for drug development decisions.

Learn more

Regulatory Affairs

End-to-end regulatory strategy and global submission support.

Learn more

Value & Access

Build sustainable pathways for innovations to reach patients.

Learn more

DMPK & Clinical Pharmacology

Advanced modeling and simulation to optimize drug development decisions and accelerate your path to market.

Our services include:

  • Non-compartmental analysis (NCA) for all clinical phases
  • Population PK/PD modeling for dose optimization
  • Exposure-response analysis and clinical trial simulations
  • Disease progression modeling and biomarker analysis
  • Quantitative systems pharmacology (QSP) modeling
  • Pediatric dose extrapolation and special populations
  • Regulatory submission support (FDA, EMA, PMDA)

Value delivered:

Accelerated development timelines, optimized dosing strategies, reduced clinical trial costs, and robust regulatory packages.

Regulatory Affairs

End-to-end regulatory strategy and global submission support to navigate complex regulatory landscapes.

Our services include:

  • Regulatory strategy development and gap analysis
  • IND, NDA, BLA submissions (FDA)
  • MAA, CTA submissions (EMA)
  • JNDA, J-IND submissions (PMDA)
  • Orphan drug and breakthrough therapy designations
  • Regulatory meeting preparation and support
  • CMC, preclinical, and clinical documentation

Value delivered:

Streamlined approval pathways, reduced regulatory risks, faster time to market, and successful global registrations.

Value, Access, Pricing & Reimbursement

We ensure your innovations reach patients by building sustainable access pathways.

Our services include:

  • Access strategy development
  • Launch price optimization
  • Reimbursement submissions and HTA support
  • HEOR strategy and real-world evidence planning
  • Cost-effectiveness and budget impact modeling
  • Patient access program design and implementation
  • Value dossier development and targeted literature reviews

Value delivered:

Improved payer engagement, data-driven pricing, and regulatory-aligned market entry.

Why Partner With Us

Specialized Expertise

Deep understanding of biopharma, medtech, and diagnostics sectors.

Tailored Solutions

Customized to your market context and organizational needs.

Impact Focus

Every engagement tied to measurable business and patient outcomes.

Get in Touch

Ready to unlock value across your product lifecycle? Let's discuss how Kalvion Sciences can help drive your success.